PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed May 16, 2008
Insider Transaction Report
Form 4
DALTON MARK F
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2008-05-14−2,500→ 0 totalExercise: $4.41From: 2003-04-01Exp: 2013-05-31→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2008-05-14$4.41/sh+2,500$11,025→ 73,500 total
Holdings
- 16,500(indirect: By Partnership)
Common Stock